Skip to content

Moleculin Biotech, Inc.

MBRX· NasdaqCore metricsCIK 1659617

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -0.18%
Market cap
$8.71M
1.06M shares
Filings
846
$0.00
Q3 2026
-$6.49M
Q3 2026N/M FY25 yoy
-$6.61M
Q3 2026N/M FY25 yoy
-$22.74M
FY 2025derivedN/M FY25 yoy
-$0.59
FY 2021N/M FY21 yoy
$7.29M
Q3 2026+107.5% FY25 yoy
$8.71M
—
—
0.6×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$8.21+1,609.38%+$7.73past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$0.000FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported
FY 20212021-12-31$0reported
FY 20202020-12-31$0reported
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported

Pharmaceutical preparations

Moleculin Biotech, Inc. is the 421st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR